ARCH THERAPEUTICS, INC.: 10-Q filed 2013-08-14
What ARCH THERAPEUTICS, INC. reported in its quarterly report filed 2013-08-14 (fiscal Q3 2013): 27 published measures, 88 facts as tagged in accession 0001144204-13-046058.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-08-14
- Fiscal period
- fiscal Q3 2013
- Accession
- 0001144204-13-046058 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARCH THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 477,551 | USD | |
| At 2012-09-30 | 21,355 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 419,267 | USD | |
| At 2012-09-30 | 2,793,790 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 58,284 | USD | |
| At 2012-09-30 | -2,772,435 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 476,369 | USD | |
| At 2012-09-30 | 17,139 | USD | |
| At 2012-06-30 | 20,149 | USD | |
| At 2011-09-30 | 36,775 | USD | |
| At 2006-03-05 | 0 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -514,361 | USD | 91 |
| 2012-10-01 to 2013-06-30 | -892,254 | USD | 273 |
| 2006-03-06 to 2013-06-30 | -3,670,333 | USD | 2674 |
| 2012-04-01 to 2012-06-30 | -176,833 | USD | 91 |
| 2011-10-01 to 2012-06-30 | -382,609 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-06-30 | -667,281 | USD | 273 |
| 2006-03-06 to 2013-06-30 | -2,641,288 | USD | 2674 |
| 2011-10-01 to 2012-06-30 | -151,625 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-06-30 | 0 | USD | 273 |
| 2006-03-06 to 2013-06-30 | 19,054 | USD | 2674 |
| 2011-10-01 to 2012-06-30 | 0 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 0 | USD | 91 |
| 2012-10-01 to 2013-06-30 | 0 | USD | 273 |
| 2006-03-06 to 2013-06-30 | 431,461 | USD | 2674 |
| 2012-04-01 to 2012-06-30 | 0 | USD | 91 |
| 2011-10-01 to 2012-06-30 | 0 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-06-30 | 1,126,512 | USD | 273 |
| 2006-03-06 to 2013-06-30 | 3,136,712 | USD | 2674 |
| 2011-10-01 to 2012-06-30 | 135,000 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-06-30 | 0 | USD | 273 |
| 2006-03-06 to 2013-06-30 | -19,054 | USD | 2674 |
| 2011-10-01 to 2012-06-30 | 0 | USD | 274 |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 8,549,322 | shares | 91 |
| 2012-10-01 to 2013-06-30 | 6,613,249 | shares | 273 |
| 2012-04-01 to 2012-06-30 | 5,638,813 | shares | 91 |
| 2011-10-01 to 2012-06-30 | 5,636,618 | shares | 274 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -0.06 | USD/shares | 91 |
| 2012-10-01 to 2013-06-30 | -0.13 | USD/shares | 273 |
| 2012-04-01 to 2012-06-30 | -0.03 | USD/shares | 91 |
| 2011-10-01 to 2012-06-30 | -0.07 | USD/shares | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 61 | USD | |
| At 2012-09-30 | 908 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -494,796 | USD | 91 |
| 2012-10-01 to 2013-06-30 | -783,921 | USD | 273 |
| 2006-03-06 to 2013-06-30 | -3,136,197 | USD | 2674 |
| 2012-04-01 to 2012-06-30 | -137,310 | USD | 91 |
| 2011-10-01 to 2012-06-30 | -268,081 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 477,490 | USD | |
| At 2012-09-30 | 20,447 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 19,596 | USD | 91 |
| 2012-10-01 to 2013-06-30 | 108,384 | USD | 273 |
| 2006-03-06 to 2013-06-30 | 588,101 | USD | 2674 |
| 2012-04-01 to 2012-06-30 | 39,233 | USD | 91 |
| 2011-10-01 to 2012-06-30 | 114,702 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 419,267 | USD | |
| At 2012-09-30 | 2,552,439 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 307,548 | USD | |
| At 2012-09-30 | 258,426 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 494,796 | USD | 91 |
| 2012-10-01 to 2013-06-30 | 783,921 | USD | 273 |
| 2006-03-06 to 2013-06-30 | 3,567,658 | USD | 2674 |
| 2012-04-01 to 2012-06-30 | 137,310 | USD | 91 |
| 2011-10-01 to 2012-06-30 | 268,081 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 43,750 | USD | 91 |
| 2012-10-01 to 2013-06-30 | 62,356 | USD | 273 |
| 2006-03-06 to 2013-06-30 | 710,128 | USD | 2674 |
| 2012-04-01 to 2012-06-30 | 18,750 | USD | 91 |
| 2011-10-01 to 2012-06-30 | 42,240 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 58,645,212 | shares | |
| At 2012-09-30 | 5,645,212 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 3,669,971 | USD | |
| At 2012-09-30 | 0 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 0 | USD | |
| At 2012-09-30 | 352,755 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,121 | USD | |
| At 2012-09-30 | 3,308 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 451,046 | USD | 91 |
| 2012-10-01 to 2013-06-30 | 721,565 | USD | 273 |
| 2006-03-06 to 2013-06-30 | 2,857,530 | USD | 2674 |
| 2012-04-01 to 2012-06-30 | 118,560 | USD | 91 |
| 2011-10-01 to 2012-06-30 | 225,841 | USD | 274 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-06-30 | 847 | USD | 273 |
| 2006-03-06 to 2013-06-30 | 18,994 | USD | 2674 |
| 2011-10-01 to 2012-06-30 | 2,589 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-06-30 | 49,122 | USD | 273 |
| 2006-03-06 to 2013-06-30 | 307,548 | USD | 2674 |
| 2011-10-01 to 2012-06-30 | 114,885 | USD | 274 |
Inspect the source
- Entity
- ARCH THERAPEUTICS, INC. / CIK 0001537561
- Captured
- SEC response SHA-256
63d0e84748ee59ab7c6817be68d0a32b23d83273213bc50081bb86253a1d4cc2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001537561.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))